A groundbreaking clinical trial has revealed that a single gene-editing infusion can lower bad cholesterol by up to 62 percent, potentially replacing the need for daily medication.
Most Recent Articles
Angiographic Collateral Scores as Predictors of Salvageable Tissue in Coronary Artery Disease
Cardiologists have discovered that a routine angiogram scoring system can evaluate the heart's natural bypass vessels to immediately identify living tissue behind long-term arterial blockages.
Three-Dimensional Microarchitectural Mapping of the Right Ventricular Bundle Branches in Congenital Heart Defects
Using high-intensity synchrotron X-rays, scientists have created highly detailed 3D maps of the heart's invisible electrical wiring to help surgeons protect pediatric patients from life-threatening postoperative arrhythmias.
Cancer-Cell Autonomous Inflammatory Signaling as a Precursor to Targeted Therapy Failure
New research shows that colorectal tumors bypass targeted therapies by activating an internal, non-genetic inflammatory alarm, which can be blocked to prevent drug resistance and relapse.
Broad Spectrum Immunogenicity of Dual-Immunogen Formulations Against Segmented RNA Viruses
Immunologists have successfully mapped the human T cell genetic targets for Lassa fever, paving the way for a universal vaccine capable of preventing multiple deadly rodent-borne outbreaks.